Egalet Corporation announced the appointment of John Varian to its board of directors. Over the past three decades, Mr. Varian has helped companies establish strategic direction, raise capital, launch pharmaceutical products, structure and negotiate corporate alliances, communicate with investors and execute business development transactions. He most recently served as the CEO and director of XOMA, an antibody business, where he led the refocusing and refinancing of the company. Prior to Xoma, Mr. Varian was the chief operating officer of Aryx Therapeutics.